NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,218 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $5,254,546 | +4.0% | 49,357 | -5.5% | 0.08% | +1.3% |
Q1 2024 | $5,052,595 | -4.4% | 52,234 | -0.2% | 0.08% | -11.4% |
Q4 2023 | $5,283,760 | -2.2% | 52,330 | -1.3% | 0.09% | -11.1% |
Q3 2023 | $5,401,432 | -0.1% | 53,028 | -1.0% | 0.10% | +4.2% |
Q2 2023 | $5,406,052 | +6.2% | 53,573 | -3.2% | 0.10% | +1.1% |
Q1 2023 | $5,089,808 | -1.7% | 55,324 | -3.1% | 0.09% | -6.9% |
Q4 2022 | $5,177,027 | +16.7% | 57,066 | -2.3% | 0.10% | +5.2% |
Q3 2022 | $4,438,000 | -9.2% | 58,385 | +1.0% | 0.10% | -6.8% |
Q2 2022 | $4,888,000 | -5.1% | 57,816 | -1.5% | 0.10% | +12.0% |
Q1 2022 | $5,150,000 | -5.3% | 58,686 | -5.6% | 0.09% | +3.4% |
Q4 2021 | $5,437,000 | -1.4% | 62,159 | -7.8% | 0.09% | -9.2% |
Q3 2021 | $5,514,000 | -21.1% | 67,423 | -12.0% | 0.10% | -27.4% |
Q2 2021 | $6,993,000 | -10.6% | 76,644 | -16.3% | 0.14% | -15.1% |
Q1 2021 | $7,824,000 | -11.2% | 91,528 | -1.9% | 0.16% | -13.6% |
Q4 2020 | $8,809,000 | -1.1% | 93,288 | -8.9% | 0.18% | -12.4% |
Q3 2020 | $8,908,000 | -1.8% | 102,443 | -1.4% | 0.21% | -6.7% |
Q2 2020 | $9,075,000 | +4.4% | 103,902 | -1.5% | 0.22% | -10.7% |
Q1 2020 | $8,694,000 | -13.8% | 105,445 | -1.1% | 0.25% | +7.2% |
Q4 2019 | $10,091,000 | +5.8% | 106,569 | -2.9% | 0.24% | -1.7% |
Q3 2019 | $9,538,000 | -1.9% | 109,754 | +3.1% | 0.24% | -6.3% |
Q2 2019 | $9,722,000 | -3.5% | 106,472 | +1.6% | 0.26% | -5.9% |
Q1 2019 | $10,077,000 | +8.0% | 104,809 | -3.6% | 0.27% | -5.2% |
Q4 2018 | $9,330,000 | -0.8% | 108,730 | -0.4% | 0.29% | +8.3% |
Q3 2018 | $9,402,000 | +11.4% | 109,127 | -2.4% | 0.26% | +3.1% |
Q2 2018 | $8,442,000 | -15.9% | 111,762 | -10.0% | 0.26% | -17.4% |
Q1 2018 | $10,037,000 | -1.3% | 124,152 | +2.5% | 0.31% | +2.6% |
Q4 2017 | $10,170,000 | -3.4% | 121,136 | -1.3% | 0.30% | -6.8% |
Q3 2017 | $10,532,000 | -0.1% | 122,679 | -2.9% | 0.32% | +0.3% |
Q2 2017 | $10,541,000 | +8.2% | 126,280 | -3.8% | 0.32% | +8.4% |
Q1 2017 | $9,745,000 | -6.4% | 131,212 | -8.2% | 0.30% | -11.6% |
Q4 2016 | $10,407,000 | -18.4% | 142,876 | -11.5% | 0.34% | -22.9% |
Q3 2016 | $12,750,000 | -6.4% | 161,468 | -2.2% | 0.44% | -8.8% |
Q2 2016 | $13,624,000 | +2.9% | 165,124 | -9.7% | 0.48% | +2.4% |
Q1 2016 | $13,244,000 | – | 182,820 | – | 0.47% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |